Exploring Innovations in Epilepsy Treatment at AES 2024
The RNS System will take center stage at this year's AES Annual Meeting, held in Los Angeles, presenting over 70 remarkable scientific discussions and posters. Excitement builds as NeuroPace gears up to showcase the latest innovations designed to enhance the treatment experience for both healthcare providers and patients.
Significant Presence at AES 2024
NeuroPace, Inc. (NASDAQ: NPCE), a pioneering medical device company, plans a robust exhibition at the annual American Epilepsy Society (AES) meeting. This event, featuring valuable contributions to the field of epilepsy treatment, is anticipated to provide an invaluable platform for sharing knowledge and advancements.
The RNS System Featured at Booth #2119
At booth #2119, NeuroPace will highlight the impressive outcomes achieved through responsive neuromodulation technology. With a reported 82% reduction in seizures over three years, the RNS System showcases significant improvements in quality of life for patients without the chronic side effects typically seen with other therapies.
Product Demonstrations and Networking Opportunities
Attendees of the AES meeting are invited to experience product demonstrations firsthand. These sessions will take place both at the NeuroPace booth and within a dedicated Tech Suite, where clinicians can provide valuable feedback on future innovations. Visitors can pre-book demos to engage with the technology that is changing lives.
Engaging Events and Sessions During AES
NeuroPace will sponsor multiple panels and networking events during AES. One highlight is an investigator meeting focusing on key clinical studies, including the Nautilus clinical trial and the RNS Post Approval Study. These discussions are essential, as they allow researchers and clinicians to evaluate ongoing advancements in epilepsy treatment.
Fellows Networking Reception
This special event, titled "Doing Well by Doing Good," is tailored for those seeking practical advice on establishing a responsive neuromodulation clinic and achieving success post-fellowship. Esteemed speakers, including Dr. Fonda Chan and Dr. Deepa Panjeti-Moore, will share their insights on optimizing care in neurology.
Product Theater Session Insights
Another exciting session, "New Frontiers in Responsive Neuromodulation," will discuss groundbreaking advancements in the field. Dr. Martha Morrell will present findings from ongoing research, emphasizing the RNS System's role in chronic intracranial EEG recordings and its effectiveness in treating various conditions.
The Vision of NeuroPace, Inc.
Based in Mountain View, NeuroPace is committed to revolutionizing how epilepsy is treated. The RNS System is recognized as the first brain-responsive platform that delivers immediate, personalized treatment, significantly enhancing the standard of care for individuals with drug-resistant epilepsy. This pioneering approach underlines NeuroPace's dedication to improving outcomes for patients facing the challenges of epilepsy.
Frequently Asked Questions
What is the RNS System and its primary benefits?
The RNS System is a brain-responsive device designed to monitor and treat epilepsy by delivering personalized therapies. Its primary benefits include a significant reduction in seizure frequency and improvement in the quality of life for patients.
Where can attendees find NeuroPace at AES 2024?
Attendees can visit NeuroPace at booth #2119 during the AES Annual Meeting to learn more about the RNS System and its innovations.
What events is NeuroPace sponsoring at AES 2024?
NeuroPace is hosting multiple events, including product demonstrations, an investigator meeting for clinical studies, and networking receptions for fellows in the field.
How does the RNS System compare to other neuromodulation therapies?
The RNS System provides a unique advantage as it is designed to deliver real-time treatment at the seizure source, reducing chronic side effects commonly linked to other therapies.
Who should attend the NeuroPace sessions at AES?
Healthcare professionals, researchers, and anyone interested in advancing knowledge in epilepsy treatment would benefit from attending NeuroPace's informational sessions.
